Sara Tolaney is appointed as Alliance for Clinical Trials in Oncology Breast Committee Vice-Chair
Alliance for Clinical Trials in Oncology recently shared on X:
“Congratulations to Sara Tolaney, MD, MPH on her appointment as Alliance for Clinical Trials in Oncology Breast Committee Vice-Chair!”
Source: Alliance for Clinical Trials in Oncology/X
Sara Tolaney is the Chief of the Division of Breast Oncology at Dana-Farber Cancer Institute. She also serves as Associate Director of the Susan F. Smith Center for Women’s Cancers and is a Senior Physician at Dana-Farber Cancer Institute and Associate Professor of Medicine at Harvard Medical School.
Her research focuses on the development of novel therapies in the treatment of breast cancer and developing more effective and less toxic treatment approaches. Her work has demonstrated that a relatively low-risk regimen is beneficial in women with early-stage node-negative HER2-positive cancers, and this works has been incorporated into national and international guidelines.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023